TY - JOUR T1 - Puzzling persisting symptoms after COVID-19 JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00709-2021 VL - 8 IS - 2 SP - 00709-2021 AU - Merel E. Hellemons Y1 - 2022/04/01 UR - http://openres.ersjournals.com/content/8/2/00709-2021.abstract N2 - There is an increasingly evident discrepancy between experienced symptoms and underlying pulmonary injury, thus motivating further research to identify the underlying mechanisms of persistent pulmonary symptoms after #COVID19 https://bit.ly/33nyUxlThe coronavirus disease 2019 (COVID-19) pandemic has held the world in its grip for the past 2 years, and with the appearance of new variants demonstrating increasing immune evasion, the end of this pandemic seems, currently, not in sight. Apart from the ongoing pandemic of acute COVID-19, data are mounting regarding the subsequent pandemic of persisting signs and symptoms post-acute COVID-19 infection [1]. These sequelae are currently termed “post-COVID-19 condition” by a World Health Organization consensus definition concerning symptoms present 3 months beyond the onset of COVID-19, persisting for ≥2 months, that may fluctuate and relapse over time, and cannot be explained by an alternative diagnosis [2]. ER -